Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000444328 | SCV000529089 | likely benign | not specified | 2016-06-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000574612 | SCV000671071 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001409035 | SCV001611045 | likely benign | Colorectal cancer, susceptibility to, 10 | 2022-10-19 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001409035 | SCV004016659 | likely benign | Colorectal cancer, susceptibility to, 10 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003922800 | SCV004737474 | likely benign | POLD1-related condition | 2019-03-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |